Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer
- Author
- FUKUOKA, Masahiro; YANO, Seiji; EEK, Richard; HORAI, Takeshi; NODA, Kazumasa; TAKATA, Ichiro; SMIT, Egbert; AVERBUCH, Steven; MACLEOD, Angela; FEYEREISLOVA, Andrea; DONG, Rui-Ping; BASELGA, José; GIACCONE, Giuseppe; TAMURA, Tomohide; NAKAGAWA, Kazuhiko; DOUILLARD, Jean-Yves; NISHIWAKI, Yutaka; VANSTEENKISTE, Johan; KUDOH, Shinzoh; RISCHIN, Danny
Academic Hospital Free University, Amsterdam, Netherlands
AstraZeneca, Alderley Park, United Kingdom
AstraZeneca, Wilmington, DE, United States
C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France
Centre for Developmental Cancer Therapeutics, Melbourne, Australia
Kanagawa Cancer Center, Yokohama, Japan
Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Japan
Mary Potter Oncology Centre, Pretoria, South Africa
National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, Japan
National Cancer Center, East Hospital, Chiba, Japan
National Shikoku Cancer Center, Matsuyama, Japan
Tokushima University School of Medicine, Tokushima, Japan
University Hospital Gasthuisberg, Leuven, Belgium
Vall d'Hebron University Hospital, Barcelona, Spain - Source
Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2237-2246, 10 p ; ref : 27 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Bronchopulmonaire Carcinome non petite cellule Chimiothérapie Complication Efficacité traitement Essai clinique phase II Etude multicentrique Homme Inhibiteur enzyme Platine Complexe Protein-tyrosine kinase Prétraitement Randomisation Stade avancé Toxicité Traitement Voie orale Géfitinib Appareil respiratoire pathologie Bronche pathologie Enzyme Poumon pathologie Transferases Tumeur maligne
- Keyword (en)
- Antineoplastic agent Bronchopulmonary Non small cell carcinoma Chemotherapy Complication Treatment efficiency Phase II trial Multicenter study Human Enzyme inhibitor Platinum Complexes Protein-tyrosine kinase Pretreatment Randomization Advanced stage Toxicity Treatment Oral administration Respiratory disease Bronchus disease Enzyme Lung disease Transferases Malignant tumor
- Keyword (es)
- Anticanceroso Broncopulmonar Carcinoma no pequeña célula Quimioterapia Complicación Eficacia tratamiento Ensayo clínico fase II Estudio multicéntrico Hombre Inhibidor enzima Platino Complejo Protein-tyrosine kinase Pretratamiento Aleatorización Estadio avanzado Toxicidad Tratamiento Vía oral Aparato respiratorio patología Bronquio patología Enzima Pulmón patología Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 14952103
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2003.10.038 
https://dx.doi.org/10.1200/JCO.2003.10.038
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2003.10.038\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2237\";s:8:\"\u0000*\u0000epage\";s:4:\"2246\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FUKUOKA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Masahiro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YANO, Seiji\";i:1;s:12:\"EEK, Richard\";i:2;s:14:\"HORAI, Takeshi\";i:3;s:14:\"NODA, Kazumasa\";i:4;s:14:\"TAKATA, Ichiro\";i:5;s:12:\"SMIT, Egbert\";i:6;s:16:\"AVERBUCH, Steven\";i:7;s:15:\"MACLEOD, Angela\";i:8;s:20:\"FEYEREISLOVA, Andrea\";i:9;s:14:\"DONG, Rui-Ping\";i:10;s:14:\"BASELGA, Jos\u00e9\";i:11;s:18:\"GIACCONE, Giuseppe\";i:12;s:16:\"TAMURA, Tomohide\";i:13;s:18:\"NAKAGAWA, Kazuhiko\";i:14;s:20:\"DOUILLARD, Jean-Yves\";i:15;s:17:\"NISHIWAKI, Yutaka\";i:16;s:20:\"VANSTEENKISTE, Johan\";i:17;s:14:\"KUDOH, Shinzoh\";i:18;s:14:\"RISCHIN, Danny\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2003.10.038\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2237\";s:8:\"\u0000*\u0000epage\";s:4:\"2246\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FUKUOKA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Masahiro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YANO, Seiji\";i:1;s:12:\"EEK, Richard\";i:2;s:14:\"HORAI, Takeshi\";i:3;s:14:\"NODA, Kazumasa\";i:4;s:14:\"TAKATA, Ichiro\";i:5;s:12:\"SMIT, Egbert\";i:6;s:16:\"AVERBUCH, Steven\";i:7;s:15:\"MACLEOD, Angela\";i:8;s:20:\"FEYEREISLOVA, Andrea\";i:9;s:14:\"DONG, Rui-Ping\";i:10;s:14:\"BASELGA, Jos\u00e9\";i:11;s:18:\"GIACCONE, Giuseppe\";i:12;s:16:\"TAMURA, Tomohide\";i:13;s:18:\"NAKAGAWA, Kazuhiko\";i:14;s:20:\"DOUILLARD, Jean-Yves\";i:15;s:17:\"NISHIWAKI, Yutaka\";i:16;s:20:\"VANSTEENKISTE, Johan\";i:17;s:14:\"KUDOH, Shinzoh\";i:18;s:14:\"RISCHIN, Danny\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2003.10.038\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2003.10.038\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2237\";s:8:\"\u0000*\u0000epage\";s:4:\"2246\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FUKUOKA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Masahiro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YANO, Seiji\";i:1;s:12:\"EEK, Richard\";i:2;s:14:\"HORAI, Takeshi\";i:3;s:14:\"NODA, Kazumasa\";i:4;s:14:\"TAKATA, Ichiro\";i:5;s:12:\"SMIT, Egbert\";i:6;s:16:\"AVERBUCH, Steven\";i:7;s:15:\"MACLEOD, Angela\";i:8;s:20:\"FEYEREISLOVA, Andrea\";i:9;s:14:\"DONG, Rui-Ping\";i:10;s:14:\"BASELGA, Jos\u00e9\";i:11;s:18:\"GIACCONE, Giuseppe\";i:12;s:16:\"TAMURA, Tomohide\";i:13;s:18:\"NAKAGAWA, Kazuhiko\";i:14;s:20:\"DOUILLARD, Jean-Yves\";i:15;s:17:\"NISHIWAKI, Yutaka\";i:16;s:20:\"VANSTEENKISTE, Johan\";i:17;s:14:\"KUDOH, Shinzoh\";i:18;s:14:\"RISCHIN, Danny\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2003.10.038\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2237\";s:8:\"\u0000*\u0000epage\";s:4:\"2246\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FUKUOKA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Masahiro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YANO, Seiji\";i:1;s:12:\"EEK, Richard\";i:2;s:14:\"HORAI, Takeshi\";i:3;s:14:\"NODA, Kazumasa\";i:4;s:14:\"TAKATA, Ichiro\";i:5;s:12:\"SMIT, Egbert\";i:6;s:16:\"AVERBUCH, Steven\";i:7;s:15:\"MACLEOD, Angela\";i:8;s:20:\"FEYEREISLOVA, Andrea\";i:9;s:14:\"DONG, Rui-Ping\";i:10;s:14:\"BASELGA, Jos\u00e9\";i:11;s:18:\"GIACCONE, Giuseppe\";i:12;s:16:\"TAMURA, Tomohide\";i:13;s:18:\"NAKAGAWA, Kazuhiko\";i:14;s:20:\"DOUILLARD, Jean-Yves\";i:15;s:17:\"NISHIWAKI, Yutaka\";i:16;s:20:\"VANSTEENKISTE, Johan\";i:17;s:14:\"KUDOH, Shinzoh\";i:18;s:14:\"RISCHIN, Danny\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2003.10.038\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2237\";s:8:\"\u0000*\u0000epage\";s:4:\"2246\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FUKUOKA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Masahiro\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:11:\"YANO, Seiji\";i:1;s:12:\"EEK, Richard\";i:2;s:14:\"HORAI, Takeshi\";i:3;s:14:\"NODA, Kazumasa\";i:4;s:14:\"TAKATA, Ichiro\";i:5;s:12:\"SMIT, Egbert\";i:6;s:16:\"AVERBUCH, Steven\";i:7;s:15:\"MACLEOD, Angela\";i:8;s:20:\"FEYEREISLOVA, Andrea\";i:9;s:14:\"DONG, Rui-Ping\";i:10;s:14:\"BASELGA, Jos\u00e9\";i:11;s:18:\"GIACCONE, Giuseppe\";i:12;s:16:\"TAMURA, Tomohide\";i:13;s:18:\"NAKAGAWA, Kazuhiko\";i:14;s:20:\"DOUILLARD, Jean-Yves\";i:15;s:17:\"NISHIWAKI, Yutaka\";i:16;s:20:\"VANSTEENKISTE, Johan\";i:17;s:14:\"KUDOH, Shinzoh\";i:18;s:14:\"RISCHIN, Danny\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
